Omni Bio Pharmaceutical, Inc. ("Omni Bio") (OTCBB: OMBP), a clinical-stage biopharmaceutical company, today announced a progress report of a new antioxidant molecule being developed by BioMimetix Pharmaceutical, Inc. ("BioMimetix"), of which Omni Bio is ...